Acquisition history Leverage the strong pedigree of Encore Vision with past acquisitions by Novartis to position partnerships as compatible with large pharmaceutical and ophthalmic portfolios, suggesting potential for contract manufacturing or white-label eyewear projects with established medical brands.

Market niche Operate as a smaller wholesale optical frame manufacturer and lab with US and Canada reach, presenting an opportunity to upsell high-margin private-label frames, custom lens coatings, or rapid-turnaround fulfillment to clinics and eyecare networks seeking reliable, responsive suppliers.

Growth opportunities Target regional ophthalmology groups and chains looking to diversify suppliers; emphasize agility, personalized service, and potential for scalable production as they contemplate expanding own eyewear assortments beyond major brands.

Technology leverage Highlight use of accessible tech stack (Squarespace, Microsoft 365, fonts and web tooling) as a basis for offering client portals, order tracking, and digital catalogs to streamline B2B purchasing and reduce procurement friction.

Financial framing With revenue in the sub-$1M range and a lean headcount, position Encore Vision as a cost-efficient partner for small to mid-sized practices; propose bundled value deals, volume discounts, or subscription-based lab services to drive steady revenue.